Sight Sciences: Pay

Sight Sciences paid its 3 named executives $4.2M in total in FY2025 (Dec). CEO Paul Badawi was paid $2.0M of that.

Pay$100 in the stock at the end of FY24 → $218
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Paul BadawiPresident and Chief Executive Officer
FY2025 (Dec)
1 year
Matthew LinkChief Commercial Officer
FY2025 (Dec)
1 year
Jeremy HaydenChief Legal Officer
FY2025 (Dec)
FY2023 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $5.3M. CEO pay of Sight Sciences for that year is not on file.

  1. 1Axogen
  2. 2Pulse Biosciences
  3. 3CareDx
  4. 4Orthopediatrics
  5. 5ClearPoint Neuro
  6. 6Iradimed
  7. 7Sight SciencesNot disclosed
  8. 8CVRxNot disclosed
  9. 9Harvard BioscienceNot disclosed
  10. 10Mesa Laboratories Inc /Co/Not disclosed
  11. 11NeuroPaceNot disclosed
  12. 12Paragon 28Not disclosed
  13. 13PulmonxNot disclosed
  14. 14RxSightNot disclosed
  15. 15Semler ScientificNot disclosed
  16. 16Senseonics HoldingsNot disclosed
  17. 17Si-BONENot disclosed
  18. 18TELA BioNot disclosed
  19. 19Treace Medical ConceptsNot disclosed
  20. 20ZynexNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.